Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

A Unique Mining Business Model Prospecting the Americas

(Click image to play video) Meet the man and the company that have created one of the most innovative and risk-deterrent concepts in mining exploration and development. Alianza Minerals Ltd. (ANZ) ( TSX-V.ANZ , OTC:TARSF , Forum ) is an early-stage explora...
Dave Jackson | March 1, 2021 |

Health Tech Firm Completes Enrollment for Female Sexual Function Trial

A Ladenburg Thalmann report reviewed the study design and purpose. In March 11 research note, Ladenburg Thalmann analyst Jeffrey Cohen reported that Viveve Medical Inc. (VIVE:NASDAQ) finished enrollment for the VIVEVE II trial of 250 patients across 19 clinical locati...
Streetwise Reports | March 18, 2019 |

Covid 19: Will pain-free, at-home screening tests be our salvation?

The world’s best defence against the spread of COVID-19 in 2021 will not be a vaccine, medical experts now say. Instead, it will be the widespread adoption of cheap, non-invasive diagnostic detection devices for coronaviruses – ones that look and function...
Marc Davis | September 1, 2020 |

F Disrespectful Fiduciary Responsibility

Concerned under the existential dread that "The robots could take over" and take control of the job of writer as easily as they did to that of the cashier or comedian, I attempted to create an article via an AI algoritm, the result .... There has been a lot of talk in the...
According to published reports | May 6, 2021 |

Applied Genetic Tech's Shares Double on 6-Month X-Linked RP Study Results

Shares of Applied Genetic Technologies skyrocketed to a new 52-week high price after the company reported positive six-month data from its ongoing Phase 1/2 clinical study for treatment in X-Linked Retinitis Pigmentosa. The firm stated that the trial data suggests durable and ...
Streetwise Reports | January 10, 2020 |

Fed Cut Equities Stimulus 86% This Week and Stocks Are Falling

What happens to the global markets when the US Fed begins to weaken stimulus activity and when the global markets must begin to function on their own? Are the global markets capable of sustaining current price levels without the Fed supporting them? A recent news article s...
Chris Vermeulen | May 1, 2020 |

U.S. Power Outages Signal 'Below-Radar Demand Driver for Fuel Cells'

An explanation is given in a Raymond James report for why fuel cells are superior over batteries for backup power generation during outages. In a May 30 research report, Raymond James analyst Pavel Molchanov made the case for using fuel cells to protect ...
Streetwise Reports | June 4, 2019 |

Look Which Precious Metal Is Beating Warren Buffett…

Way back in January, I showed you that the price of gold had beaten the S&P 500 Index over a number of different time periods, including the month, quarter, year… and even the century (so far!). Last week it was brought to my attention recently—in a tweet b...
Frank Holmes | September 16, 2019 |

Axsome Therapeutics Shares Open 82% Higher on Phase 3 MDD Trial Outcome

Axsome Therapeutics shares reached a new 52-week high price today after the company reported that its AXS-05 drug achieved primary endpoint in the GEMINI Phase 3 trial in Major Depressive Disorder. The firm indicated that the positive results support a New Drug Application fil...
Streetwise Reports | December 17, 2019 |

Will the Second Wave Trigger Rally in Gold?

The initial health crisis seems to be under control in many countries. But this is not the end of pandemic and many epidemiologist warn against the second wave of injections. We invite you to read our today’s article about the second wave of the new coronavirus...
Arkadiusz Sieron | June 19, 2020 |
1 2 3 4 5 6 7 8 9 10 ...